Sino Biopharmaceutical Li... (SBHMY)

PNK: SBHMY · Real-Time Price · USD

9.48

-0.82 (-7.96%)

At close: Apr 21, 2025, 3:37 PM

Sino Biopharmaceutical Cash Flow Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	5.93B	5.78B	18.57B	5.01B	5.58B	11.43B	4.2B	3.2B
Depreciation & Amortization	1.07B	1.05B	992.56M	1.65B	1.45B	1.18B	343.39M	317.4M
Stock-Based Compensation	18.12M	29.72M	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	250.19M	195.51M	-281.66M	482.78M	170.79M	781.67M	509.83M	798.21M
Other Non-Cash Items	-529.74M	-394.56M	-13.86B	-1.6B	-1.43B	-7.75B	-1.24B	-848.68M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-430.51M	-195.59M	-339.13M	261.33M	-278.65M	243.3M	430.68M	322.65M
Operating Cash Flow	6.07B	6.27B	5.37B	5.33B	5.32B	5.09B	3.73B	2.99B
Capital Expenditures	-1.7B	-1.71B	-1.89B	-1.86B	-1.73B	-1.69B	-1.46B	-893.86M
Cash Acquisitions	-742.71M	-146.17M	-958.7M	-4.2B	-221.67M	1.2B	-288.4M	-28.31M
Purchase of Investments	-1.65B	-4.48B	-4.85B	-7.16B	-2.89B	-2.45B	-1.41B	-1.56B
Sales Maturities Of Investments	2.56B	1.08B	903.24M	5.12B	914.27M	2.17B	419.08M	135.74M
Other Investing Acitivies	142.09M	722.65M	4.28B	-184.45M	-172.66M	17.27M	709.34M	-4.93M
Investing Cash Flow	-756.98M	-4.07B	-2.52B	-7.85B	-3.82B	-616.1M	-1.63B	-2.23B
Debt Repayment	-1.75B	1.05B	-1.64B	5.39B	5.2B	304.67M	-97.24M	1.6B
Common Stock Repurchased	-396.39M	-867.61M	-332.93M	-195.37M	-32.05M	-604.42M	n/a	n/a
Dividend Paid	-632.67M	-1.27B	-938.49M	-1.19B	-819.69M	-710.33M	-449.96M	-375.57M
Other Financial Acitivies	-3.77B	-2.1B	-316.24M	-1.77B	-1.55B	-1.17B	-1.15B	-658.91M
Financial Cash Flow	-6.55B	-3.19B	-3.23B	2.23B	2.8B	-2.18B	-1.7B	567.38M
Net Cash Flow	-1.15B	-944.73M	-1.02B	-7.02M	4.4B	2.54B	189.61M	1.38B
Free Cash Flow	4.36B	4.56B	3.47B	3.47B	3.59B	3.4B	2.27B	2.1B